Table 4.
Values of TNF- α, IL-6, IL-8, MFI total score and fatigue symptom dimensions in group (A) and group (B) at the end of the study
| Mean + SD | t-value | Significance | ||
| Group (A) | Group (B) | |||
| TNF-α (pg/mL) | 4.37 ± 1.48* | 6.11 ± 1.42 | 7.15 | P <0.05 |
| IL-6 (pg/mL) | 5.04 ± 1.92* | 6.57 ± 2.18 | 5.91 | P <0.05 |
| IL-8 (pg/mL) | 12.03 ± 3.61* | 14.25 ± 3.70 | 7.71 | P <0.05 |
| BMI (kg/m2) | 26.82 ± 4.88* | 31.42 ± 5.38 | 7.23 | P<0.05 |
| MFI total score | 41.11± 13.72* | 55.03 ± 12.10 | 6.31 | P <0.05 |
| Fatigue symptom dimensions | ||||
| General fatigue | 9.52± 3.61* | 13.26 ± 3.13 | 5.16 | P <0.05 |
| Physical fatigue | 8.74 ± 2.92* | 12.14 ± 3.14 | 6.42 | P <0.05 |
|
Reduced activity |
8.15± 3.43* | 11.35 ± 3.32 | 5.38 | P <0.05 |
| Mental fatigue | 7.54± 3.24* | 9.16 ±3.43 | 6.53 | P <0.05 |
|
Reduced motivation |
7.16 ± 3.41* | 9.12 ± 2.25 | 5.17 | P <0.05 |
TNF- α: tumor necrosis factor - alpha; IL-6: Interleukin-6; BMI: Body Mass Index; IL-8: Interleukin-8; MFI: Multidimensional Fatigue Inventory;
*
indicates a significant difference between the two groups, P < 0.05.